By: Martin David Harp, Ms, Nisha Acharya
Uveitis expert Nisha Acharya, recipient of ARVO’s Mildred Weisenfeld Award, discusses how clinical trials and big data are reshaping treatment, vaccination, and vision outcomes.
United States (National)
Martin David Harp
Geo Focus
Coverage Attributes:
Beta
Informative:
47
%
Data Driven:
28
%
Interviews Q&as:
7
%
Events:
6
%
Promotional:
6
%
Themes Covered:
Not enough data
Pitching Insights
Martin David Harp's coverage predominantly focuses on ophthalmology, eye care, and FDA approvals within the healthcare and pharmaceutical industry. His articles often cite data and include press releases or announcements from relevant companies or organizations in this field.
Based on his focus, Martin would likely value pitches that offer insights into groundbreaking medical advances in ophthalmology, particularly those related to new treatments, technologies, or FDA approvals. Given the emphasis on citing data and expert commentary in his coverage attributes, he may be receptive to pitches featuring credible experts who can provide insightful analysis of the latest developments in these areas.
As a journalist with a national focus on Australia but covering international topics such as COVID-19 impact on ophthalmology education in the UK, it could be beneficial to tailor pitches by highlighting any relevance or implications for the Australian context when applicable.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data
Journalist
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
